Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gzyl, A.
Right arrow Articles by Slusarczyk, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gzyl, A.
Right arrow Articles by Slusarczyk, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology, Volume 33, Number 2, pp. 358-365
IJE vol.33 no.2 © International Epidemiological Association 2004; all rights reserved.


Article

Pertussis in Poland

Anna Gzyl1, Ewa Augustynowicz1, Daniel Rabczenko2, Grzegorz Gniadek1 and Janusz Slusarczyk1

1 Department of Sera and Vaccines Evaluation, National Institute of Hygiene, 24 Chocimska Str., 00-791 Warsaw, Poland
2 Department of Medical Statistics, National Institute of Hygiene, 24 Chocimska Str., 00-791 Warsaw, Poland

Correspondence: Anna Gzyl, Department of Sera and Vaccines Evaluation, National Institute of Hygiene, 24 Chocimska Str., 00–791 Warsaw, Poland. E-mail: agzyl{at}pzh.gov.pl

Background Since 1997, an unexpected 2–5-fold increase in the incidence of pertussis has been reported in Poland in comparison with the previous 10 years, although the introduction of the diphtheria-tetanus-pertussis (DTP) vaccination in 1960 reduced the incidence of pertussis approximately 100-fold in the 1980s. The aim of the study was to analyse all available data on pertussis in Poland to identify the risks associated with its re-emergence.

Methods Available data on notification, incidence, mortality, hospitalization, geographical distribution, incidence according to age, and diagnosis of pertussis were collected from national surveillance monographs and statistically evaluated.

Results Analyses performed in the study found two periods of rising and falling trends: in the incidence before and after 1989, respectively. Moreover, after 1989, the age-specific incidence among children aged 0–4 years decreased, and among 5–9, 10–14, and 15–19 year olds increased in comparison to the previous decade. The incidence rate of pertussis among infants was similar in both decades analysed. Clustering of pertussis incidence increase in provinces along a line from North East to South West was observed.

Conclusions As vaccination coverage did not decrease and diagnostics have not been improved since the 1980s, it is possible that waning immunity and the appearance of Bordetella pertussis vaccine escape mutants are involved in the changing pertussis epidemiological parameters. Further monitoring studies, together with improving diagnostics, might allow more precise epidemiological data to be obtained. An additional booster dose of acellular pertussis vaccine at age 6 years has been included in the current vaccination schedule.


Keywords Pertussis, DTP, Poland

Accepted 6 August 2003


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Infect. Immun.Home page
R. M. Stenger, M. C. M. Poelen, E. E. Moret, B. Kuipers, S. C. M. Bruijns, P. Hoogerhout, M. Hijnen, A. J. King, F. R. Mooi, C. J. P. Boog, et al.
Immunodominance in Mouse and Human CD4+ T-Cell Responses Specific for the Bordetella pertussis Virulence Factor P.69 Pertactin
Infect. Immun., February 1, 2009; 77(2): 896 - 903.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
Y.-C. Lin, S.-M. Yao, J.-J. Yan, Y.-Y. Chen, C.-S. Chiang, H.-S. Wu, and S.-Y. Li
Epidemiological shift in the prevalence of pertussis in Taiwan: implications for pertussis vaccination
J. Med. Microbiol., April 1, 2007; 56(4): 533 - 537.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. Niedziela, I. Letowska, J. Lukasiewicz, M. Kaszowska, A. Czarnecka, L. Kenne, and C. Lugowski
Epitope of the Vaccine-Type Bordetella pertussis Strain 186 Lipooligosaccharide and Antiendotoxin Activity of Antibodies Directed against the Terminal Pentasaccharide-Tetanus Toxoid Conjugate
Infect. Immun., November 1, 2005; 73(11): 7381 - 7389.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
A. Elomaa, A. Advani, D. Donnelly, M. Antila, J. Mertsola, H. Hallander, and Q. He
Strain Variation among Bordetella pertussis Isolates in Finland, Where the Whole-Cell Pertussis Vaccine Has Been Used for 50 Years
J. Clin. Microbiol., August 1, 2005; 43(8): 3681 - 3687.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
H. O. Hallander, A. Advani, D. Donnelly, L. Gustafsson, and R.-M. Carlsson
Shifts of Bordetella pertussis Variants in Sweden from 1970 to 2003, during Three Periods Marked by Different Vaccination Programs
J. Clin. Microbiol., June 1, 2005; 43(6): 2856 - 2865.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
K. M Edwards and N. B Halasa
Commentary: Is pertussis disease increasing?
Int. J. Epidemiol., April 1, 2004; 33(2): 365 - 366.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.